Bone Biologics Corp (BBLG)

Bone Biologics Corp (BBLG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.1M; returns 1 day -2.7%, 1 week -0.1%, 1 year -82.1%.

Bone Biologics Corp (BBLG) is a clinical-stage biotechnology company focused on developing orthobiologic products for the spine fusion market. Their primary focus is on bone regeneration using NELL-1-based technology.

Groups BBLG belongs to

• Biotechnology
• Orthopedics
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Regenerative Medicine
• Medical Devices

BBLG financial model: income statement, cash flow and balance sheet